OTC
15 articole · RSS
Romanian Consumers Spent EUR1.4B on OTC Drugs in 2022
Sales of over-the-counter (OTC) drugs reached RON6.7 billion (almost EUR1.4 billion) in 2022, up 23% from the previous year, data from market research company Cegedim show.
Biofarm Posts RON30M Net Profit in H1
Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from...
Romania OTC Drug Market Reaches RON810M In 2Q/2018
Romania’s over-the-counter (OTC) medicines, also called non-prescription medicines, market had a stable evolution in the second quarter of 2018, reaching sales of RON810.2 million. The sales...
Romanian OTC Drug Market Grows 13% in 1Q, to RON880M
Sales of over-the-counter (OTC) medicines topped RON880 million in Romania in the first quarter, up 13% on the year, the local producers association said Tuesday citing Cegedim data.
Reckitt Benckiser, Terapia And Biofarm Account For 20% Of OTC Market
Reckitt Benckiser, the company that owns the Nurofen brand, Terapia and Biofarm, both of which with local manufacturing operations, account for 20% of the over-the-counter drug market, which...
Top Five OTC Drugs In Romania See EUR74M Sales
The best-selling over the counter (OTC) drugs in Romania are Nurofen of Reckitt Benckiser, followed by Aspenter (Terapia Cluj), Parasinus (GlaxoSmithKline) and No-Spa (Sanofi), according to...
Sales Of OTC Drugs Up Four-Fold In 12 Years
Sales of over-the-counter drugs in Romania went up from 600 million lei (EUR133 million) in 2004 to RON2.4 billion in July 2015 – June 2016, according to market research company Cegedim. Thi...
Terapia Cluj: OTC Drugs Now Account For 50% Of Our Portfolio
Pharmaceutical drug manufacturer Terapia Cluj, a member of the Indian pharmaceutical group Sun Pharma, has boosted share of over-the-counter drugs to 50% of its product portfolio, double as...
Romanians Spent EUR670 Million On Over The Counter Drugs In 2014
Sales of over-the-counter (non-prescription) drugs stood at EUR673 million in Romania last year and accounted for 12.7% of the sales in the region, according to ZF’s calculations based on th...